Company Summary
Foldax, the creator of TRIA™ heart valves, are the world’s first polymeric aortic, TAVR, and mitral valves – and are designed to last a lifetime. Foldax’s goal is to help millions of patients with heart valve disease receive a cost-effective, long-lasting treatment while avoiding long-term reliance on blood thinning and anti-rejection medications.